Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO4916 | Toxicodendron vernicifluum | Species | Anacardiaceae | Eukaryota | TM-MC* | |||
NPO5140 | Dipteryx odorata | Species | Fabaceae | Eukaryota | Seeds |
PMID[12762787] |
||
NPO24559 | Cotinus coggygria | Species | Anacardiaceae | Eukaryota | Whole plant |
PMID[11141121] |
||
NPO20782 | Philodendron hederaceum | Species | Araceae | Eukaryota | UNPD* | |||
NPO17550 | Origanum onites | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO20623 | Dendrobium farmeri | Species | Orchidaceae | Eukaryota | UNPD* | |||
NPO19860 | Jasminum sambac | Species | Oleaceae | Eukaryota | UNPD* | |||
NPO19597 | Populus sieboldi | Species | Salicaceae | Eukaryota | UNPD* | |||
NPO19470 | Xanthorrhoea minor | Species | Asphodelaceae | Eukaryota | UNPD* | |||
NPO18625 | Chlorocodon whitei | NA | NA | NA | UNPD* | |||
NPO18385 | Rabdosia parvifolia | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO12181 | Albizia julibrissin | Species | Fabaceae | Eukaryota | TM-MC* | |||
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT440 | Individual Protein | Quinone oxidoreductase | Mus musculus | CD | = | 20.7 | nM | 12762787 |
NPT2 | Others | Unspecified | IC50 | = | 78500 | nM | 12762787 | |
NPT2 | Others | Unspecified | Ratio | = | 3.8 | 12762787 | ||
NPT2 | Others | Unspecified | Inhibition | = | 58.5 | % | 12762787 | |
NPT1 | Others | Radical scavenging activity | IC50 | = | 16.1 | ug/ml | 11141121 | |
NPT493 | Individual Protein | Neuraminidase | Influenza A virus | IC50 | = | 29600 | nM | 18640042 |
NPT493 | Individual Protein | Neuraminidase | Influenza A virus | IC50 | = | 51200 | nM | 18640042 |
NPT493 | Individual Protein | Neuraminidase | Influenza A virus | IC50 | = | 36200 | nM | 18640042 |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | CC50 | = | 27440 | nM | 18640042 |
NPT742 | Organism | Influenza A virus | Influenza A virus | IC50 | > | 9150 | nM | 18640042 |
NPT1602 | Individual Protein | Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 | = | 8 | ug/ml | 20116898 |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 89125.1 | nM | PubChem BioAssay data set |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 8260.4 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 17782.8 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 29092.9 | nM | PubChem BioAssay data set | |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 56234.1 | nM | PubChem BioAssay data set |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT57 | Individual Protein | Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens | IC50 | = | 1534.63 | nM | PubChem BioAssay data set |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT60 | Individual Protein | Lysosomal alpha-glucosidase | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT4624 | Individual Protein | Relaxin receptor 2 | Homo sapiens | Potency | 43620.6 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 6012 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 13459.1 | nM | PubChem BioAssay data set | |
NPT799 | Individual Protein | Intestinal alkaline phosphatase | Mus musculus | IC50 | = | 19700 | nM | PubChem BioAssay data set |
NPT2944 | Individual Protein | Relaxin receptor 1 | Homo sapiens | Potency | 48943.1 | nM | PubChem BioAssay data set | |
NPT798 | Individual Protein | Alkaline phosphatase placental-like | Homo sapiens | IC50 | = | 67200 | nM | PubChem BioAssay data set |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 14575 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 6309.6 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT4625 | Individual Protein | Vasopressin V1b receptor | Homo sapiens | Potency | 43620.6 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 11577.4 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 3793.3 | nM | PubChem BioAssay data set | |
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | IC50 | = | 52900 | nM | PubChem BioAssay data set |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | IC50 | = | 66300 | nM | PubChem BioAssay data set |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 28970 | nM | 21723122 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 5900 | nM | 21723122 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 80680 | nM | 21723122 |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set | ||
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT84 | Individual Protein | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus | AC50 | = | 2320 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 15101.4 | nM | PubChem BioAssay data set | |
NPT2534 | Individual Protein | Thrombin | Bos taurus | IC50 | = | 21700 | nM | PubChem BioAssay data set |
NPT4626 | Individual Protein | Multidrug resistance protein CDR2 | Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast) | EC50 | 424 | nM | PubChem BioAssay data set | |
NPT2971 | Individual Protein | DNA dC->dU-editing enzyme APOBEC-3F | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT4627 | Individual Protein | 26S proteasome non-ATPase regulatory subunit 14 | Homo sapiens | IC50 | = | 23800 | nM | PubChem BioAssay data set |
NPT568 | Individual Protein | Matrix metalloproteinase-2 | Homo sapiens | IC50 | > | 100000 | nM | PubChem BioAssay data set |
NPT1852 | Individual Protein | Rac GTPase-activating protein 1 | Homo sapiens | IC50 | 20560 | nM | PubChem BioAssay data set | |
NPT477 | Individual Protein | DNA dC->dU-editing enzyme APOBEC-3G | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 28220 | nM | PubChem BioAssay data set | ||
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 2238.7 | nM | PubChem BioAssay data set | |
NPT157 | Individual Protein | Breast cancer type 1 susceptibility protein | Homo sapiens | Potency | 6309.6 | nM | PubChem BioAssay data set | |
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT1853 | Individual Protein | Putative uncharacterized protein | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT1417 | Individual Protein | Transcriptional regulator ERG | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 24.44 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | -2.22 | % | 23062825 |
NPT2 | Others | Unspecified | Potency | 23109.3 | nM | PubChem BioAssay data set | ||
NPT1509 | Protein Complex | Cyclin-dependent kinase 5/CDK5 activator 1 | Homo sapiens | IC50 | = | 37030 | nM | 23927974 |
NPT2 | Others | Unspecified | Potency | 3548.1 | nM | PubChem BioAssay data set | ||
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 125892.5 | nM | PubChem BioAssay data set | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 33807.8 | nM | PubChem BioAssay data set | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 23778.1 | nM | PubChem BioAssay data set | |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT441 | Individual Protein | Cytochrome P450 19A1 | Homo sapiens | Activity | = | 99 | % | 24630560 |
NPT3902 | Individual Protein | Acetylcholinesterase | Mus musculus | IC50 | = | 698880 | nM | 25468034 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 81.3 | % | 26238320 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC140840 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC86847 |
0.9929 | High Similarity | NPC19545 |
0.979 | High Similarity | NPC260582 |
0.9655 | High Similarity | NPC304954 |
0.9589 | High Similarity | NPC189130 |
0.958 | High Similarity | NPC74881 |
0.958 | High Similarity | NPC51443 |
0.951 | High Similarity | NPC20791 |
0.951 | High Similarity | NPC179271 |
0.9452 | High Similarity | NPC260895 |
0.9441 | High Similarity | NPC70136 |
0.9384 | High Similarity | NPC149127 |
0.9384 | High Similarity | NPC286342 |
0.9384 | High Similarity | NPC188871 |
0.9375 | High Similarity | NPC169749 |
0.9371 | High Similarity | NPC279121 |
0.9357 | High Similarity | NPC254841 |
0.9333 | High Similarity | NPC195832 |
0.9329 | High Similarity | NPC472461 |
0.9315 | High Similarity | NPC270465 |
0.9315 | High Similarity | NPC87125 |
0.9315 | High Similarity | NPC195351 |
0.931 | High Similarity | NPC168803 |
0.931 | High Similarity | NPC95864 |
0.9301 | High Similarity | NPC175013 |
0.9257 | High Similarity | NPC55205 |
0.9257 | High Similarity | NPC82325 |
0.9257 | High Similarity | NPC279989 |
0.9252 | High Similarity | NPC77858 |
0.9247 | High Similarity | NPC196277 |
0.9247 | High Similarity | NPC272721 |
0.9247 | High Similarity | NPC12367 |
0.9247 | High Similarity | NPC118726 |
0.9247 | High Similarity | NPC43669 |
0.9231 | High Similarity | NPC284556 |
0.9231 | High Similarity | NPC301178 |
0.9211 | High Similarity | NPC231758 |
0.92 | High Similarity | NPC265511 |
0.9195 | High Similarity | NPC246328 |
0.9195 | High Similarity | NPC325028 |
0.9195 | High Similarity | NPC179126 |
0.9195 | High Similarity | NPC256346 |
0.9195 | High Similarity | NPC141212 |
0.9195 | High Similarity | NPC27532 |
0.9195 | High Similarity | NPC270620 |
0.9195 | High Similarity | NPC236223 |
0.9195 | High Similarity | NPC78326 |
0.9189 | High Similarity | NPC54394 |
0.9189 | High Similarity | NPC225731 |
0.9189 | High Similarity | NPC252933 |
0.9189 | High Similarity | NPC125062 |
0.9189 | High Similarity | NPC200740 |
0.9184 | High Similarity | NPC1612 |
0.9184 | High Similarity | NPC183959 |
0.9184 | High Similarity | NPC105512 |
0.9178 | High Similarity | NPC239312 |
0.9178 | High Similarity | NPC130230 |
0.9178 | High Similarity | NPC77378 |
0.9178 | High Similarity | NPC275772 |
0.9178 | High Similarity | NPC108406 |
0.9167 | High Similarity | NPC471417 |
0.9167 | High Similarity | NPC287722 |
0.915 | High Similarity | NPC272722 |
0.9133 | High Similarity | NPC80534 |
0.9133 | High Similarity | NPC133392 |
0.9133 | High Similarity | NPC214138 |
0.9133 | High Similarity | NPC56786 |
0.9128 | High Similarity | NPC36835 |
0.9128 | High Similarity | NPC240476 |
0.9128 | High Similarity | NPC9743 |
0.9128 | High Similarity | NPC246162 |
0.9128 | High Similarity | NPC27208 |
0.9128 | High Similarity | NPC123886 |
0.9128 | High Similarity | NPC125300 |
0.9128 | High Similarity | NPC63187 |
0.9128 | High Similarity | NPC61506 |
0.9128 | High Similarity | NPC37684 |
0.9128 | High Similarity | NPC157784 |
0.9128 | High Similarity | NPC260491 |
0.9122 | High Similarity | NPC29231 |
0.9122 | High Similarity | NPC45873 |
0.9116 | High Similarity | NPC119059 |
0.9116 | High Similarity | NPC194856 |
0.9116 | High Similarity | NPC3036 |
0.9116 | High Similarity | NPC321011 |
0.9116 | High Similarity | NPC276930 |
0.9116 | High Similarity | NPC294852 |
0.9116 | High Similarity | NPC188679 |
0.9103 | High Similarity | NPC242893 |
0.9103 | High Similarity | NPC38065 |
0.9091 | High Similarity | NPC39305 |
0.9091 | High Similarity | NPC1706 |
0.9091 | High Similarity | NPC59295 |
0.9091 | High Similarity | NPC472582 |
0.9091 | High Similarity | NPC263092 |
0.9091 | High Similarity | NPC1755 |
0.9073 | High Similarity | NPC245546 |
0.9073 | High Similarity | NPC153512 |
0.9073 | High Similarity | NPC471500 |
0.9073 | High Similarity | NPC266960 |
0.9073 | High Similarity | NPC43243 |
0.9073 | High Similarity | NPC474638 |
0.9067 | High Similarity | NPC58382 |
0.9067 | High Similarity | NPC162351 |
0.906 | High Similarity | NPC154345 |
0.906 | High Similarity | NPC31363 |
0.906 | High Similarity | NPC28274 |
0.906 | High Similarity | NPC205046 |
0.906 | High Similarity | NPC59162 |
0.906 | High Similarity | NPC236769 |
0.906 | High Similarity | NPC133953 |
0.906 | High Similarity | NPC251110 |
0.906 | High Similarity | NPC50403 |
0.906 | High Similarity | NPC304295 |
0.9054 | High Similarity | NPC259713 |
0.9054 | High Similarity | NPC296197 |
0.9054 | High Similarity | NPC137062 |
0.9054 | High Similarity | NPC287101 |
0.9054 | High Similarity | NPC52005 |
0.9054 | High Similarity | NPC183950 |
0.9054 | High Similarity | NPC216318 |
0.9054 | High Similarity | NPC159103 |
0.9054 | High Similarity | NPC17286 |
0.9054 | High Similarity | NPC223579 |
0.9048 | High Similarity | NPC207729 |
0.9048 | High Similarity | NPC117463 |
0.9034 | High Similarity | NPC471520 |
0.9034 | High Similarity | NPC254659 |
0.9032 | High Similarity | NPC36320 |
0.9026 | High Similarity | NPC238995 |
0.902 | High Similarity | NPC269906 |
0.9013 | High Similarity | NPC101830 |
0.9013 | High Similarity | NPC203891 |
0.9013 | High Similarity | NPC471479 |
0.9013 | High Similarity | NPC287979 |
0.9013 | High Similarity | NPC52530 |
0.9013 | High Similarity | NPC163524 |
0.9013 | High Similarity | NPC67876 |
0.9013 | High Similarity | NPC305663 |
0.9013 | High Similarity | NPC110070 |
0.9013 | High Similarity | NPC471515 |
0.9013 | High Similarity | NPC176665 |
0.9007 | High Similarity | NPC26227 |
0.9007 | High Similarity | NPC44079 |
0.9007 | High Similarity | NPC201451 |
0.9 | High Similarity | NPC60972 |
0.9 | High Similarity | NPC39732 |
0.9 | High Similarity | NPC257648 |
0.9 | High Similarity | NPC19721 |
0.9 | High Similarity | NPC28103 |
0.9 | High Similarity | NPC477231 |
0.8993 | High Similarity | NPC62042 |
0.8993 | High Similarity | NPC3825 |
0.8993 | High Similarity | NPC166753 |
0.8993 | High Similarity | NPC248102 |
0.8993 | High Similarity | NPC184136 |
0.8993 | High Similarity | NPC88804 |
0.8993 | High Similarity | NPC61620 |
0.8993 | High Similarity | NPC50728 |
0.8986 | High Similarity | NPC120464 |
0.8973 | High Similarity | NPC59551 |
0.8973 | High Similarity | NPC142165 |
0.8966 | High Similarity | NPC310128 |
0.8954 | High Similarity | NPC19687 |
0.8954 | High Similarity | NPC115798 |
0.8954 | High Similarity | NPC204854 |
0.8954 | High Similarity | NPC4481 |
0.8954 | High Similarity | NPC143828 |
0.8954 | High Similarity | NPC25495 |
0.8954 | High Similarity | NPC18772 |
0.8954 | High Similarity | NPC7846 |
0.8954 | High Similarity | NPC55738 |
0.8954 | High Similarity | NPC16935 |
0.8954 | High Similarity | NPC105242 |
0.8954 | High Similarity | NPC18607 |
0.8954 | High Similarity | NPC130894 |
0.8954 | High Similarity | NPC300943 |
0.8954 | High Similarity | NPC176300 |
0.8954 | High Similarity | NPC191459 |
0.8954 | High Similarity | NPC253634 |
0.8954 | High Similarity | NPC261004 |
0.8954 | High Similarity | NPC193842 |
0.8954 | High Similarity | NPC22472 |
0.8954 | High Similarity | NPC288669 |
0.8954 | High Similarity | NPC152166 |
0.8954 | High Similarity | NPC9609 |
0.8951 | High Similarity | NPC299379 |
0.8947 | High Similarity | NPC3980 |
0.8947 | High Similarity | NPC201837 |
0.8947 | High Similarity | NPC49824 |
0.8947 | High Similarity | NPC247017 |
0.8947 | High Similarity | NPC13858 |
0.8947 | High Similarity | NPC55619 |
0.8947 | High Similarity | NPC320825 |
0.8947 | High Similarity | NPC100916 |
0.8947 | High Similarity | NPC326037 |
0.8947 | High Similarity | NPC200388 |
0.8947 | High Similarity | NPC292107 |
0.8947 | High Similarity | NPC98661 |
0.894 | High Similarity | NPC292214 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC140840 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.951 | High Similarity | NPD1512 | Approved |
0.9459 | High Similarity | NPD3882 | Suspended |
0.9371 | High Similarity | NPD1511 | Approved |
0.8874 | High Similarity | NPD1934 | Approved |
0.8816 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8816 | High Similarity | NPD2801 | Approved |
0.8662 | High Similarity | NPD943 | Approved |
0.8636 | High Similarity | NPD3817 | Phase 2 |
0.863 | High Similarity | NPD1549 | Phase 2 |
0.8591 | High Similarity | NPD6799 | Approved |
0.8562 | High Similarity | NPD3818 | Discontinued |
0.8562 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.8562 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.8553 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.8553 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8553 | High Similarity | NPD6166 | Phase 2 |
0.8552 | High Similarity | NPD1510 | Phase 2 |
0.8533 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8531 | High Similarity | NPD1240 | Approved |
0.8414 | Intermediate Similarity | NPD1607 | Approved |
0.8408 | Intermediate Similarity | NPD7075 | Discontinued |
0.8405 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8354 | Intermediate Similarity | NPD919 | Approved |
0.8354 | Intermediate Similarity | NPD7251 | Discontinued |
0.8333 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8303 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8299 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8258 | Intermediate Similarity | NPD6599 | Discontinued |
0.825 | Intermediate Similarity | NPD1247 | Approved |
0.8228 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8193 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8171 | Intermediate Similarity | NPD7054 | Approved |
0.817 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8153 | Intermediate Similarity | NPD6801 | Discontinued |
0.8148 | Intermediate Similarity | NPD3926 | Phase 2 |
0.8141 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8133 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8121 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8121 | Intermediate Similarity | NPD7472 | Approved |
0.8121 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8121 | Intermediate Similarity | NPD2796 | Approved |
0.8101 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8075 | Intermediate Similarity | NPD5494 | Approved |
0.8065 | Intermediate Similarity | NPD5403 | Approved |
0.8063 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8063 | Intermediate Similarity | NPD3749 | Approved |
0.8052 | Intermediate Similarity | NPD5401 | Approved |
0.805 | Intermediate Similarity | NPD5402 | Approved |
0.8026 | Intermediate Similarity | NPD3750 | Approved |
0.8 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7987 | Intermediate Similarity | NPD7819 | Suspended |
0.7973 | Intermediate Similarity | NPD230 | Phase 1 |
0.7964 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7961 | Intermediate Similarity | NPD1243 | Approved |
0.7961 | Intermediate Similarity | NPD2800 | Approved |
0.7947 | Intermediate Similarity | NPD2344 | Approved |
0.7931 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7917 | Intermediate Similarity | NPD1203 | Approved |
0.7862 | Intermediate Similarity | NPD7411 | Suspended |
0.7852 | Intermediate Similarity | NPD447 | Suspended |
0.7844 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7826 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7806 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD1613 | Approved |
0.7758 | Intermediate Similarity | NPD6232 | Discontinued |
0.7742 | Intermediate Similarity | NPD2309 | Approved |
0.7725 | Intermediate Similarity | NPD7473 | Discontinued |
0.7722 | Intermediate Similarity | NPD920 | Approved |
0.7722 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7707 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7706 | Intermediate Similarity | NPD6559 | Discontinued |
0.7697 | Intermediate Similarity | NPD3748 | Approved |
0.7651 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD2935 | Discontinued |
0.7605 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7597 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7595 | Intermediate Similarity | NPD2533 | Approved |
0.7595 | Intermediate Similarity | NPD2534 | Approved |
0.7595 | Intermediate Similarity | NPD2532 | Approved |
0.759 | Intermediate Similarity | NPD6959 | Discontinued |
0.7586 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7586 | Intermediate Similarity | NPD9717 | Approved |
0.7582 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7574 | Intermediate Similarity | NPD3751 | Discontinued |
0.7568 | Intermediate Similarity | NPD9494 | Approved |
0.7564 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7561 | Intermediate Similarity | NPD7768 | Phase 2 |
0.756 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7529 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7516 | Intermediate Similarity | NPD6190 | Approved |
0.75 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD2799 | Discontinued |
0.7452 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7421 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7419 | Intermediate Similarity | NPD6100 | Approved |
0.7419 | Intermediate Similarity | NPD6099 | Approved |
0.7417 | Intermediate Similarity | NPD2313 | Discontinued |
0.7417 | Intermediate Similarity | NPD411 | Approved |
0.7415 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7407 | Intermediate Similarity | NPD3226 | Approved |
0.7397 | Intermediate Similarity | NPD422 | Phase 1 |
0.7397 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD1933 | Approved |
0.7381 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7361 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7356 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7351 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7347 | Intermediate Similarity | NPD1608 | Approved |
0.7341 | Intermediate Similarity | NPD5953 | Discontinued |
0.7338 | Intermediate Similarity | NPD6651 | Approved |
0.7337 | Intermediate Similarity | NPD3787 | Discontinued |
0.731 | Intermediate Similarity | NPD9268 | Approved |
0.7296 | Intermediate Similarity | NPD2354 | Approved |
0.7285 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7279 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7278 | Intermediate Similarity | NPD2654 | Approved |
0.7273 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD2346 | Discontinued |
0.7251 | Intermediate Similarity | NPD2403 | Approved |
0.7239 | Intermediate Similarity | NPD1653 | Approved |
0.7233 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7232 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7225 | Intermediate Similarity | NPD7286 | Phase 2 |
0.72 | Intermediate Similarity | NPD1470 | Approved |
0.719 | Intermediate Similarity | NPD3764 | Approved |
0.7186 | Intermediate Similarity | NPD2296 | Approved |
0.7168 | Intermediate Similarity | NPD2163 | Approved |
0.7162 | Intermediate Similarity | NPD1201 | Approved |
0.7161 | Intermediate Similarity | NPD6355 | Discontinued |
0.716 | Intermediate Similarity | NPD6234 | Discontinued |
0.7158 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD2798 | Approved |
0.7143 | Intermediate Similarity | NPD17 | Approved |
0.7135 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7133 | Intermediate Similarity | NPD3225 | Approved |
0.7127 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7123 | Intermediate Similarity | NPD9545 | Approved |
0.7111 | Intermediate Similarity | NPD4287 | Approved |
0.7103 | Intermediate Similarity | NPD9493 | Approved |
0.7099 | Intermediate Similarity | NPD7390 | Discontinued |
0.7095 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7086 | Intermediate Similarity | NPD1729 | Discontinued |
0.7083 | Intermediate Similarity | NPD4288 | Approved |
0.7078 | Intermediate Similarity | NPD6798 | Discontinued |
0.7078 | Intermediate Similarity | NPD3268 | Approved |
0.7078 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7059 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7055 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7044 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7044 | Intermediate Similarity | NPD2353 | Approved |
0.7035 | Intermediate Similarity | NPD5711 | Approved |
0.7035 | Intermediate Similarity | NPD5710 | Approved |
0.7025 | Intermediate Similarity | NPD7033 | Discontinued |
0.7017 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7014 | Intermediate Similarity | NPD1241 | Discontinued |
0.7012 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7 | Intermediate Similarity | NPD1481 | Phase 2 |
0.6994 | Remote Similarity | NPD4357 | Discontinued |
0.6987 | Remote Similarity | NPD4060 | Phase 1 |
0.6986 | Remote Similarity | NPD405 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD2797 | Approved |
0.6974 | Remote Similarity | NPD1164 | Approved |
0.6968 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6964 | Remote Similarity | NPD37 | Approved |
0.6954 | Remote Similarity | NPD7784 | Clinical (unspecified phase) |
0.6941 | Remote Similarity | NPD4965 | Approved |
0.6941 | Remote Similarity | NPD4967 | Phase 2 |
0.6941 | Remote Similarity | NPD4966 | Approved |
0.6939 | Remote Similarity | NPD5536 | Phase 2 |
0.6933 | Remote Similarity | NPD1535 | Discovery |
0.6928 | Remote Similarity | NPD1019 | Discontinued |
0.6923 | Remote Similarity | NPD6233 | Phase 2 |
0.6919 | Remote Similarity | NPD4361 | Phase 2 |
0.6919 | Remote Similarity | NPD4362 | Clinical (unspecified phase) |
0.691 | Remote Similarity | NPD7685 | Pre-registration |
0.6903 | Remote Similarity | NPD4625 | Phase 3 |
0.6903 | Remote Similarity | NPD7095 | Approved |
0.6901 | Remote Similarity | NPD6971 | Discontinued |
0.6897 | Remote Similarity | NPD5242 | Approved |
0.6887 | Remote Similarity | NPD3972 | Approved |
0.6883 | Remote Similarity | NPD3018 | Phase 2 |
0.6879 | Remote Similarity | NPD4307 | Phase 2 |
0.6879 | Remote Similarity | NPD1558 | Phase 1 |
0.6875 | Remote Similarity | NPD228 | Approved |
0.6875 | Remote Similarity | NPD5404 | Approved |
0.6875 | Remote Similarity | NPD5406 | Approved |
0.6875 | Remote Similarity | NPD5408 | Approved |
0.6875 | Remote Similarity | NPD5405 | Approved |
0.6875 | Remote Similarity | NPD7228 | Approved |
0.6871 | Remote Similarity | NPD3887 | Approved |
0.6863 | Remote Similarity | NPD3267 | Approved |
0.6863 | Remote Similarity | NPD3266 | Approved |
0.6857 | Remote Similarity | NPD4575 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD4749 | Approved |
0.6842 | Remote Similarity | NPD5019 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD7229 | Phase 3 |
0.6833 | Remote Similarity | NPD8312 | Approved |
0.6833 | Remote Similarity | NPD8313 | Approved |
PubChem CID   | 5281295 |
ChEMBL   | CHEMBL490355 |
ZINC   |
Molecular Weight:   | 270.05 |
ALogP:   | -1.7778 |
MLogP:   | 2.56 |
XLogP:   | 2.329 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 86.99 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 20 |